Formulation Characterisation & Development

Research scientists at i2c have extensive development experience across a range of inhalation products including pMDIs, DPIs, small volume liquid inhalers and nebulisers. We provide a responsive, client-centric service. Our research facilities enable us to rapidly characterise, refine and optimise formulations and to conduct stability studies under standard ICH conditions. In conjunction with Simbec-Orion, i2c’s broad service offering extends to supporting clinical development programs.

Formulation development support functions include:
  • Aerosol particle sizing and inhaler performance characterisation
  • Dose uniformity and potency tests
  • Disintegration & dissolution testing of oral dosage forms
  • Powder characterisation
  • Analytical methods development and optimisation
  • Moisture content
  • Accelerated stability testing

What We Do

Formulation: Characterisation
& Development

Small Scale Manufacture
& Testing

Clinical Gamma